The Boston Globe

Isomorphic Labs sets up US presence in Cambridge, with an eye on clinical trials

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. As Isomorphic Labs aims its artificial ...
Hindustan Times

Isomorphic Labs’ AI designed drugs are about to hit human trials

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...
Proactiveinvestors

Alphabet’s Isomorphic Labs set to begin human trials for AI-developed drugs

Founded in 2021 out of DeepMind’s AlphaFold protein modelling system, Isomorphic blends AI expertise with pharmaceutical science to develop drugs faster and more accurately. Colin Murdoch, president ...
NDTV

Google Ready To Start Human Trials Of Its AI-Designed Drugs

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper and ...
pharmaphorum

Alphabet's DeepMind forms AI drug discovery unit Isomorphic Labs

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...